- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00575835
Oral Vitamin D Supplementation in Elderly Women
December 26, 2007 updated by: University of Helsinki
Oral Vitamin D Supplementation in Elderly Women: Twice a Day or Three Times a Year? A Randomised Controlled Trial
The aim of this study is to compare oral vitamin D supplementation administered in two different ways, namely either twice a day (800IU/d, 292000IU/y) or three times a year (97333IU every 4 months, 292000IU/y) in elderly women in combination with daily supplementation of calcium 1 gram.
We will 1)compare the blood concentrations of 25 OH vitamin D in the two treatment groups amd monitor if a sufficient and safe concentration of 25OH D in blood can be maintained with these two treatments.2) Find out seasonal variation in vitamin D concentrations in these treatments.
3) Find out safety of these treatments
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
40
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Helsinki, Finland, 00029 HUS
- Helsinki University Central Hospital, department of medicine, division of endocrinology
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
70 years to 80 years (Older Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
Female
Description
Inclusion Criteria:
- Females
- 70-80 years
- Living in the community
Exclusion Criteria:
- Renal disease
- Diseases that contraindicate vitamin D supplementation
- Medications affecting bone
- Malignancy
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: 2
|
Vigantol oil , D3 20000IU/ml, 4.9 ml every four months for one year
|
Active Comparator: 1
|
Kalsipos-D, vitamin D3 400 ID/tbl, 2 tbl/day for one year
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Blood 25 OH D vitamin concentrations
Time Frame: 8 times during the year
|
8 times during the year
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
serum calcium, 24-hour calcium excretion in urine, creatinine clearance
Time Frame: 8 times during the year
|
8 times during the year
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
October 1, 2006
Study Completion (Actual)
October 1, 2007
Study Registration Dates
First Submitted
December 17, 2007
First Submitted That Met QC Criteria
December 17, 2007
First Posted (Estimate)
December 18, 2007
Study Record Updates
Last Update Posted (Estimate)
January 8, 2008
Last Update Submitted That Met QC Criteria
December 26, 2007
Last Verified
December 1, 2007
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 77/2006
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Optimal Vitamin D Administration
-
University of UlsterNorthern Ireland Executive; HSC Public Health AgencyCompletedVitamin D Status | Vitamin D ConcentrationUnited Kingdom
-
Queen's University, BelfastNorthern Ireland Chest Heart and Stroke; HSC Research & Development Division... and other collaboratorsCompletedInsulin Resistance | Pre-diabetes | Sub-optimal Vitamin D StatusUnited Kingdom
-
Hospices Civils de LyonCompleted
-
Horopito LimitedAtlantia Food Clinical TrialsCompleted
-
Federal University of Rio Grande do SulCompletedDeficiency, Vitamin DBrazil
-
University Hospital, Clermont-FerrandTerminated
-
Factors Group of Nutritional Companies Inc.Completed
-
Mike O'Callaghan Military HospitalWithdrawnVitamin DUnited States
-
King's College LondonVitamax Wholesalers LLPRecruiting
-
Boston UniversityPure North S'Energy FoundationCompletedVitamin D InsufficiencyUnited States
Clinical Trials on vitamin D twice daily
-
Ain Shams UniversityRecruiting
-
Galderma R&DCompleted
-
Dr. Reddy's Laboratories LimitedCompleted
-
Murdoch Childrens Research InstituteSuspended
-
Manal AbdelmalekCompletedNonalcoholic SteatohepatitisUnited States
-
Yale UniversityNot yet recruitingVitamin D Deficiency | Polycystic Ovarian Syndrome in Adolescent Females
-
Spectrum Pharmaceuticals, IncTerminated
-
First Affiliated Hospital of Zhejiang UniversityXiangya Hospital of Central South University; Second Affiliated Hospital, School... and other collaboratorsRecruitingHematologic Malignancy | Bronchiolitis Obliterans SyndromeChina
-
National Hepatology & Tropical Medicine Research...Completed
-
Unity Health TorontoCompleted